FC
VIR icon

FORA Capital’s Vir Biotechnology VIR Stock Holding History

FORA Capital’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,732
Closed -$69.5K – 713
2025
Q1 		$69.5K Buy
+10,732
New +$95.4K 0.01% 470
2021
Q3 		– Sell
-2,806
Closed -$133K – 863
2021
Q2 		$133K Buy
+2,806
New +$128K 0.02% 531
2021
Q1 		– Sell
-565
Closed -$15K – 1130
2020
Q4 		$15K Buy
+565
New +$18.4K ﹤0.01% 890
2020
Q3 		– Sell
-11,268
Closed -$462K – 1007
2020
Q2 		$462K Buy
+11,268
New +$378K 0.16% 169

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return